Artal Group’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
2024
Q1
$10.6M Buy
2021
Q1
Sell
2020
Q4
$7.01M Buy
2018
Q1
Sell
2017
Q4
$995K Sell
2017
Q3
$1.93M Hold
2017
Q2
$1.67M Hold
2017
Q1
$2.44M Hold
2016
Q4
$2.39M Hold
2016
Q3
$2.73M Hold
2016
Q2
$2.96M Hold
2016
Q1
$2.55M Buy
2015
Q4
$5.88M Hold
2015
Q3
$3.95M Buy
2015
Q2
$6.3M Buy